Lung adenocarcinoma with predominantly alveolar type is of intermediate malignancy, which is closely related to the degree of cell differentiation and proliferation.
Lung adenocarcinoma includes 5 types of clinicopathological classification, namely adnexal type, alveolar type, papillary type, micropapillary type and solid type, among which the alveolar type belongs to the middle-differentiated type, with medium cell proliferation, and the overall malignancy is medium among all lung adenocarcinomas, and the specific treatment needs to be judged in combination with the stage of the disease.
If alveolar type lung adenocarcinoma is found to be predominantly in early stage, radical resection should be performed as early as possible through surgery, and standardized radiotherapy and chemotherapy should be provided in combination with immunohistochemistry and clinical staging.
After diagnosis of lung adenocarcinoma, timely and standardized treatment should be carried out under the guidance of specialists, which is conducive to improving the quality of survival.